Health

Dr. Dean Ornish from the University of California San Francisco has discovered that an intensive lifestyle intervention may help slow down early Alzheimer’s disease. During his research, he found that the only side effects of this intervention were positive ones. This groundbreaking discovery could potentially change the way we approach treating Alzheimer’s disease in the
0 Comments
The landscape of healthcare delivery has been drastically changed by the recent COVID-19 pandemic, prompting a shift towards remote monitoring and telemedicine. During a late-breaking abstract session at the European Alliance of Associations for Rheumatology (EULAR) annual meeting, Dr. Inger Jorid Berg presented findings from a randomized trial that evaluated different approaches to follow-up care
0 Comments
Air pollution is a growing concern not only for the environment but also for human health, particularly for pregnant women. Recent studies have uncovered a troubling connection between maternal exposure to particulate matter (PM) and adverse outcomes during pregnancy, specifically related to blood pressure issues. This overlooked risk to maternal health highlights the urgent need
0 Comments
Advancements in the field of oncology have paved the way for innovative treatment options for patients with non-small cell lung cancer (NSCLC). In a recent phase II study conducted in collaboration with UT Southwestern, patients with EGFR-mutant NSCLC were treated with osimertinib alone or in combination with stereotactic ablative radiation therapy (SABR). The study aimed
0 Comments
The story of Barbara Quarrell, a cancer patient who was denied care at Memorial Medical Center in Las Cruces, New Mexico, highlights a troubling trend in the healthcare system. The hospital, now owned by private equity-backed Lifepoint Health, refused to accept Barbara’s insurance, leaving her with limited options for treatment. This case is not isolated,
0 Comments
Donanemab, an investigational drug for treating early Alzheimer’s disease, has recently received unanimous support from an FDA advisory committee. The committee’s 11-0 vote affirmed that the benefits of donanemab outweigh its risks for Alzheimer’s patients with mild cognitive impairment and mild dementia enrolled in clinical trials. Furthermore, the committee agreed that available data demonstrated the
0 Comments
Physicians like Anthony Fauci and Jason Liebowitz are facing unique challenges in their respective fields of expertise. The pressure is evident when Rep. Jamie Raskin mentions that he is not a comic book super-villain, highlighting the immense scrutiny and expectations placed on healthcare professionals. Meanwhile, Jason Liebowitz’s statement about being replaceable sheds light on the
0 Comments
The SYNERGY-NASH phase II study demonstrated the efficacy of tirzepatide in resolving metabolic dysfunction-associated steatohepatitis (MASH) and liver fibrosis. The trial conducted by Dr. Rohit Loomba involved 190 participants with biopsy-confirmed MASH and fibrosis. The results indicated a significant resolution of MASH without worsening of fibrosis in patients treated with tirzepatide compared to those in
0 Comments